  | Van Aerschot, L., Demeyer, S., Timcheva, K., Heylen, E., Verstraete, P., De Groote, D., Caruso, M., Lauwereins, L., Bacquelaine Veloso, A., Kampen, K. R., Pepe, D., Boeckx, N., Royaert, J., Verbeeck, J., Segers, H., Cools, J., De Keersmaecker, K., & Granados, D. C. (2026). NKX2-1 regulates cell survival, maturation, and DNA-damage responses as a cofactor of RUNX1 in T-cell acute lymphoblastic leukemia. Haematologica. doi:10.3324/haematol.2025.287966  Peer Reviewed verified by ORBi |
 | Lauwereins, L., Van Thillo, Q., Demeyer, S., Mentens, N., Provost, S., Jacobs, K., Gielen, O., Boogaerts, L., de Bock, C. E., Andrieu, G., Asnafi, V., Cools, J., & Bacquelaine Veloso, A. (March 2025). TLE4 is a repressor of the oncogenic activity of TLX3 in T-cell acute lymphoblastic leukemia. Leukemia, 39 (3), 568 - 576. doi:10.1038/s41375-025-02513-w Peer Reviewed verified by ORBi |
 | Cardoso, B. A., Duque, M., Gírio, A., Fragoso, R., Oliveira, M. L., Allen, J. R., Martins, L. R., Correia, N. C., Silveira, A. B., Bacquelaine Veloso, A., Kimura, S., Demoen, L., Matthijssens, F., Jeha, S., Cheng, C., Pui, C.-H., Grosso, A. R., Neto, J. L., De Almeida, S. F., ... Barata, J. T. (01 June 2024). CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia. Haematologica, 109 (6), 1713 - 1725. doi:10.3324/haematol.2023.282854 Peer Reviewed verified by ORBi |
 | Veloso, A.* , Bleuart, A.* , Conrard, L., Orban, T., Bruyr, J., Cabochette, P., Germano, R. F. V., Schevenels, G., Bernard, A., Zindy, E., Demeyer, S., Vanhollebeke, B., Dequiedt, F.* , & Martin, M.*. (27 February 2024). The cytoskeleton adaptor protein Sorbs1 controls the development of lymphatic and venous vessels in zebrafish. BMC Biology, 22 (1), 51. doi:10.1186/s12915-024-01850-z Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Bacquelaine Veloso, A., & Cools, J. (20 July 2023). Targeting STAT5B in T-cell acute lymphoblastic leukemia. Blood, 142 (3), 215 - 217. doi:10.1182/blood.2023020639 Peer Reviewed verified by ORBi |
 | Laukkanen, S.* , Bacquelaine Veloso, A.* , Yan, C., Oksa, L., Alpert, E. J., Do, D., Hyvärinen, N., McCarthy, K., Adhikari, A., Yang, Q., Iyer, S., Garcia, S. P., Pello, A., Ruokoranta, T., Moisio, S., Adhikari, S., Yoder, J. A., Gallagher, K., Whelton, L., ... Langenau, D. M.*. (27 October 2022). Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia. Blood, 140 (17), 1891 - 1906. doi:10.1182/blood.2021015106 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Oliveira, M. L., Bacquelaine Veloso, A., Garcia, E. G., Iyer, S., Pereira, C., Barreto, V. M., Langenau, D. M., & Barata, J. T. (June 2022). Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia. Leukemia, 36 (6), 1533 - 1540. doi:10.1038/s41375-022-01590-5 Peer Reviewed verified by ORBi |
 | Yan, C., Yang, Q., Zhang, S., Millar, D. G., Alpert, E. J., Do, D., Bacquelaine Veloso, A., Brunson, D. C., Drapkin, B. J., Stanzione, M., Scarfò, I., Moore, J. C., Iyer, S., Qin, Q., Wei, Y., McCarthy, K. M., Rawls, J. F., Dyson, N. J., Cobbold, M., ... Langenau, D. M. (04 October 2021). Single-cell imaging of T cell immunotherapy responses in vivo. Journal of Experimental Medicine, 218 (10). doi:10.1084/jem.20210314 Peer Reviewed verified by ORBi |
 | Garcia, E. G., Bacquelaine Veloso, A., Oliveira, M. L., Allen, J. R., Loontiens, S., Brunson, D., Do, D., Yan, C., Morris, R., Iyer, S., Garcia, S. P., Iftimia, N., Van Loocke, W., Matthijssens, F., McCarthy, K., Barata, J. T., Speleman, F., Taghon, T., Gutierrez, A., ... Langenau, D. M. (March 2021). PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis. Leukemia, 35 (3), 679 - 690. doi:10.1038/s41375-020-0937-3 Peer Reviewed verified by ORBi |
 | Veloso, A., Martin, M., Bruyr, J., O'Grady, T., Deroanne, C., Mottet, D., Twizere, J.-C., Cherrier, T.* , & Dequiedt, F.*. (2019). Dephosphorylation of HDAC4 by PP2A-Bdelta unravels a new role for the HDAC4/MEF2 axis in myoblast fusion. Cell Death and Disease, 10 (7), 512. doi:10.1038/s41419-019-1743-6 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Martin, M., Bacquelaine Veloso, A., Wu, J., Katrukha, E. A., & Akhmanova, A. (16 March 2018). Control of endothelial cell polarity and sprouting angiogenesis by non-centrosomal microtubules. eLife, 7. doi:10.7554/eLife.33864 Peer Reviewed verified by ORBi |
 | Bacquelaine Veloso, A., Slegers, T., Schoenaker, J., Demeyer, S., den Bergh, S. V., Aertgeerts, M., Verhoeft, K., Schoenmaekers, Y., Meeuws, N., Bischops, I., Renard, F., Boogaerts, L., Mentens, N., Gielen, O., Jacobs, K., Segers, H., Cools, J., Dierickx, D., & Bempt, M. V. (2024). Dual targeting of EZH2 and Histone Deacetylases in hematological malignancies promotes transcriptional and metabolic deregulation leading to ferroptosis. BioRxiv. doi:10.1101/2024.03.03.583195 |
